Perinatal Mental Health: Counseling During Pregnancy and Postpartum

Understanding Perinatal Mental Health

Perinatal mental health encompasses the psychological well-being of individuals during pregnancy (prenatal) and the first year after childbirth (postpartum). Perinatal mood and anxiety disorders (PMADs) are the most common complications of childbirth, affecting approximately 1 in 5 birthing individuals. Despite their prevalence, PMADs are frequently underdiagnosed and undertreated, with significant consequences for the parent, infant, and family. Counselors across all settings should be prepared to screen for, assess, and treat perinatal mental health conditions.

Perinatal Mood and Anxiety Disorders

Postpartum Blues (Baby Blues)

Postpartum blues affect up to 80% of new parents and typically begin within the first few days after delivery. Symptoms include mood swings, crying spells, anxiety, irritability, and difficulty sleeping. The baby blues are considered a normal response to hormonal changes, sleep deprivation, and the stress of new parenthood. They typically resolve within two weeks without treatment. When symptoms persist beyond two weeks or intensify, screening for postpartum depression is warranted.

Postpartum Depression (PPD)

PPD affects approximately 10 to 15% of birthing individuals and can develop anytime during the first year postpartum. Symptoms include persistent sadness, loss of interest in activities (including the baby), changes in appetite and sleep, fatigue, feelings of worthlessness or guilt, difficulty bonding with the baby, withdrawal from family and friends, and in severe cases, thoughts of harming oneself or the baby. PPD is clinically distinct from baby blues in its severity, duration, and functional impact.

Postpartum Anxiety

Postpartum anxiety, including generalized anxiety, panic disorder, and OCD, may be as common as postpartum depression. Symptoms include excessive worry (often about the baby's health and safety), racing thoughts, inability to relax, sleep disturbance (beyond what is expected with a newborn), and physical symptoms such as heart palpitations and nausea. Intrusive thoughts about harm coming to the baby are particularly distressing and are associated with postpartum OCD.

Postpartum Psychosis

Postpartum psychosis is a rare but severe condition affecting approximately 1 to 2 per 1,000 deliveries. It typically emerges within the first two weeks postpartum and is characterized by delusions, hallucinations, confusion, disorientation, and rapidly shifting mood. Postpartum psychosis is a psychiatric emergency requiring immediate hospitalization. Risk factors include a history of bipolar disorder or previous postpartum psychosis.

Risk Factors for PMADs

Personal or family history of depression, anxiety, or bipolar disorder
Previous episode of PMAD
Lack of social support
Relationship difficulties
Financial stress
Pregnancy or birth complications
Unplanned or unwanted pregnancy
History of trauma, particularly childhood or sexual trauma
Infant complications or NICU admission

Screening

The Edinburgh Postnatal Depression Scale (EPDS) is the most widely used screening tool for perinatal depression and anxiety. It is a 10-item self-report questionnaire validated for use during pregnancy and postpartum. The Patient Health Questionnaire (PHQ-9) is also commonly used. Universal screening is recommended at multiple time points during pregnancy and postpartum.

Evidence-Based Treatments

Psychotherapy

CBT and IPT are the two most evidence-based psychotherapeutic approaches for perinatal depression. IPT is particularly well-suited because it directly addresses the role transitions, relationship changes, and social support issues central to the perinatal period. Mother-infant therapy can address bonding difficulties and support the developing parent-infant relationship.

Medication

SSRIs are the most commonly prescribed medications for perinatal depression and anxiety. Decisions about medication during pregnancy and breastfeeding involve careful risk-benefit analysis in collaboration with the prescriber. Brexanolone (Zulresso), approved in 2019, was the first medication specifically approved for postpartum depression.

Exam Tips

PMADs affect approximately 1 in 5 birthing individuals
Baby blues resolve within two weeks; PPD persists and is more severe
Postpartum psychosis is a psychiatric emergency requiring hospitalization
The EPDS (Edinburgh Postnatal Depression Scale) is the primary screening tool
IPT is particularly well-suited for perinatal depression due to its focus on role transitions
PPD can develop anytime during the first year postpartum, not only in the first weeks